1Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant pleural effusion[ J]. Cancer Metastasis Rev, 1987,6 ( 1 ) : 108 - 113.
2Antony VB, Loddenkemper R, Sahn SA, et al. Management of malignant pleural effusions [ J]. Eur Respir J, 2001,18 ( 2 ) : 402 - 419.
3Awasthi A, Gupta N, Srinivasan R, et al. Cyto - pathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India [ J ]. Cytopathology,2007,18 ( 1 ) :28 .- 32.
4DeCamp MM, Mentzer SJ, Swanson SJ, et al. Malignant effusive disease of the pleura and pericardium [ J ]. Chest, 1997,112 (suppl4) : 291s -295s.
5Martinez - Moragon E, Aparieio J, Sanchis J, et al. Malignant pleural effusion : prognostic factors for survival and response to chemical pleurodesis in a series of 120 eases[ J]. Respiration, 1998,65 : 108 -113.
6Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions [ J ]. Chest, 2000,117(1) :79 -86.
7Antunes G, Neville E, Duffy J, et al. BTS Pleural Disease Group, a subcommittee of the BTS Standards of Care Committee. BTS guidehnes for the management of malignant pleural effusions [ J ]. Thorax ,2003,58 ( suppl2 ) : ii29 - ii38.
8Ong KC,Indumathi V,Raghuram J,et al. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions [ J ]. Respirology, 2000,5 ( 2 ) : 99 - 103.
9Kilic D, Akay H, Kavukcu S, et al. Management of recurrent malignant pleural effusion with chemical pleurodesis [ J ]. Surg Today, 2005,35:634 - 638.
10Kelly - Garcia J, Roman - Berumen JF, lbarra - Perez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms [ J]. Arch Med Res, 1997,28 (4) :583 - 585.
